Literature DB >> 17969461

Idiopathic hypersomnia: a study of 77 cases.

Kirstie N Anderson1, Samantha Pilsworth, Linda D Sharples, Ian E Smith, John M Shneerson.   

Abstract

STUDY
OBJECTIVES: To review the clinical and polysomnographic characteristics of idiopathic hypersomnia as well as the long-term response to treatment.
SETTING: The Respiratory Support and Sleep Centre at Papworth Hospital, Cambridge, UK. PATIENTS AND
DESIGN: A large database of more than 6000 patients with sleep disorders was reviewed. A retrospective study of the clinical and polysomnographic characteristics of 77 patients with idiopathic hypersomnia was performed. Comparison with a similar group of patients with narcolepsy was performed. The response to drug treatment was assessed in 61 patients over a mean follow-up of 3.8 years. MEASUREMENTS AND
RESULTS: Idiopathic hypersomnia was 60% as prevalent as narcolepsy. Comparison with a similar group of patients with narcolepsy showed that those with idiopathic hypersomnia were more likely to have prolonged unrefreshing daytime naps, a positive family history, increased slow-wave sleep, and a longer sleep latency on the Multiple Sleep Latency Test. The results of the Multiple Sleep Latency Test were not helpful in predicting disease severity or treatment response. The clinical features were heterogeneous and of variable severity. The majority of patients with idiopathic hypersomnia had symptoms that remained stable over many years, but 11% had spontaneous remission, which was never seen in narcolepsy. Two thirds of patients with idiopathic hypersomnolence had a sustained improvement in daytime somnolence with medication, although a third needed high doses or combinations of drugs.
CONCLUSIONS: Idiopathic hypersomnolence has characteristic clinical and polysomnographic features but the prolonged latency on the Multiple Sleep Latency Test raises doubt about the validity of this test within the current diagnostic criteria. The disease often responds well to treatment and a substantial minority of patients appear to spontaneously improve.

Entities:  

Mesh:

Year:  2007        PMID: 17969461      PMCID: PMC2266276          DOI: 10.1093/sleep/30.10.1274

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  21 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness.

Authors:  M A Carskadon; W C Dement; M M Mitler; T Roth; P R Westbrook; S Keenan
Journal:  Sleep       Date:  1986-12       Impact factor: 5.849

3.  Difference in the characteristics of subjective and objective sleepiness between narcolepsy and essential hypersomnia.

Authors:  Yoko Komada; Yuichi Inoue; Junko Mukai; Shuichiro Shirakawa; Kiyohisa Takahashi; Yutaka Honda
Journal:  Psychiatry Clin Neurosci       Date:  2005-04       Impact factor: 5.188

4.  Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan.

Authors:  Maurice M Ohayon; Mary A Carskadon; Christian Guilleminault; Michael V Vitiello
Journal:  Sleep       Date:  2004-11-01       Impact factor: 5.849

5.  Comparison of the results of the Epworth Sleepiness Scale and the Multiple Sleep Latency Test.

Authors:  R D Chervin; M S Aldrich; R Pickett; C Guilleminault
Journal:  J Psychosom Res       Date:  1997-02       Impact factor: 3.006

6.  Sleepiness in different situations measured by the Epworth Sleepiness Scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1994-12       Impact factor: 5.849

7.  Idiopathic Hypersomnia.

Authors:  M Billiard; Y Dauvilliers
Journal:  Sleep Med Rev       Date:  2001-10       Impact factor: 11.609

8.  Study of a patient population investigated for excessive daytime sleepiness (EDS).

Authors:  F Laffont; A Mallet; G Mayer; S Meunier; M Minz; S N'Doye; M A Quilfen-Buzare
Journal:  Neurophysiol Clin       Date:  2002-12       Impact factor: 3.734

9.  The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort.

Authors:  C Hublin; J Kaprio; M Partinen; M Koskenvuo; K Heikkila; S Koskimies; C Guilleminault
Journal:  Ann Neurol       Date:  1994-06       Impact factor: 10.422

10.  HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence.

Authors:  G Poirier; J Montplaisir; F Décary; D Momège; A Lebrun
Journal:  Sleep       Date:  1986       Impact factor: 5.849

View more
  42 in total

Review 1.  Idiopathic Hypersomnia.

Authors:  Lynn Marie Trotti
Journal:  Sleep Med Clin       Date:  2017-06-16

2.  Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology.

Authors:  Maurice M Ohayon; Yves Dauvilliers; Charles F Reynolds
Journal:  Arch Gen Psychiatry       Date:  2012-01

Review 3.  Waking up is the hardest thing I do all day: Sleep inertia and sleep drunkenness.

Authors:  Lynn M Trotti
Journal:  Sleep Med Rev       Date:  2016-09-04       Impact factor: 11.609

4.  Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.

Authors:  Christian R Baumann; Emmanuel Mignot; Gert Jan Lammers; Sebastiaan Overeem; Isabelle Arnulf; David Rye; Yves Dauvilliers; Makoto Honda; Judith A Owens; Giuseppe Plazzi; Thomas E Scammell
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

5.  miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias.

Authors:  Anja Holm; Claus Heiner Bang-Berthelsen; Stine Knudsen; Birgitte R Kornum; Signe Modvig; Poul Jennum; Steen Gammeltoft
Journal:  Sleep       Date:  2014-09-01       Impact factor: 5.849

6.  Nocturnal sleep architecture in idiopathic hypersomnia: a systematic review and meta-analysis.

Authors:  David T Plante
Journal:  Sleep Med       Date:  2017-11-02       Impact factor: 3.492

7.  Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry.

Authors:  Lynn Marie Trotti; Jason C Ong; David T Plante; Catherine Friederich Murray; Rebecca King; Donald L Bliwise
Journal:  Sleep Med       Date:  2020-09-02       Impact factor: 3.492

8.  Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Catherine Koola; Vincent LaBarbera; Donald L Bliwise; David B Rye
Journal:  J Clin Sleep Med       Date:  2016-10-15       Impact factor: 4.062

9.  Psychosocial Characteristics of Children with Central Disorders of Hypersomnolence Versus Matched Healthy Children.

Authors:  Kristin T Avis; Jiabin Shen; Patrick Weaver; David C Schwebel
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

10.  Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia).

Authors:  Taku Miyagawa; Makoto Honda; Minae Kawashima; Mihoko Shimada; Susumu Tanaka; Yutaka Honda; Katsushi Tokunaga
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.